Dietary linoleic acid supplementation fails to rescue established cardiomyopathy in Barth syndrome. [PDF]
Zhu S +7 more
europepmc +1 more source
Temporal Effects of Safflower Oil Diet-Based Linoleic Acid Supplementation on Barth Syndrome Cardiomyopathy. [PDF]
Zhu S +10 more
europepmc +1 more source
A Barth Syndrome Patient-Derived D75H Point Mutation in TAFAZZIN Drives Progressive Cardiomyopathy in Mice. [PDF]
Snider PL +14 more
europepmc +1 more source
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy. [PDF]
Hachmann M +10 more
europepmc +1 more source
Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts. [PDF]
Mejia EM +3 more
europepmc +1 more source
Clinical laboratory studies in Barth Syndrome
Barth Syndrome is a rare X-linked disorder characterized principally by dilated cardiomyopathy, skeletal myopathy and neutropenia and caused by defects in tafazzin, an enzyme responsible for modifying the acyl chain moieties of cardiolipin. While several
Hilary Vernon, Yana Sandlers
exaly +2 more sources
Mutation Characterization and Genotype-Phenotype Correlation in Barth Syndrome [PDF]
SummaryBarth syndrome is an X-linked cardiomyopathy with neutropenia and 3-methylglutaconic aciduria. Recently, mutations in the G4.5 gene, located in Xq28, have been described in four probands with Barth syndrome. We have now evaluated 14 Barth syndrome
Vicky L Funanage +2 more
exaly +2 more sources
Related searches:
Clinical presentation and natural history of Barth Syndrome: An overview
Journal of Inherited Metabolic Disease, 2022Hilary Vernon +2 more
exaly
A Bayesian Analysis to Determine the Prevalence of Barth Syndrome in the Pediatric Population
Journal of Pediatrics, 2020Michael Schlame +2 more
exaly

